Thies Tabea, Mallick Elisa, Tröger Johannes, Baykara Ebru, Mücke Doris, Barbe Michael T
University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany.
University of Cologne, Faculty of Arts and Humanities, IfL Phonetics, Cologne, Germany.
NPJ Parkinsons Dis. 2025 May 2;11(1):105. doi: 10.1038/s41531-025-00959-4.
It is still under debate whether levodopa treatment improves speech functions in Parkinson's disease (PD). Therefore, speech functions of people with PD were compared in medication-OFF condition (withdrawal of PD medication for at least 12 h) and medication-ON condition (after receiving 200 mg of soluble levodopa). A total of 78 participants, including 51 males and 27 females, performed predefined standard speech tasks. Acoustic speech features were automatically extracted with the algorithm given by the Dysarthria Analyzer. Results suggest that acute levodopa intake improves phonatory-respiratory speech functions and speech planning abilities, while the articulatory system remains unaffected. Furthermore, the study provided preliminary evidence that speech function is able to predict the medication status in individuals with PD as the constructed speech-based biomarker score did not only correlate with established measures of (speech) motor impairment but could also differentiate between the medication OFF and ON status. A post-hoc machine learning model yielded similar results.
左旋多巴治疗是否能改善帕金森病(PD)患者的言语功能仍存在争议。因此,研究人员比较了PD患者在停药状态(停用PD药物至少12小时)和服药状态(服用200毫克可溶性左旋多巴后)的言语功能。共有78名参与者,包括51名男性和27名女性,完成了预先定义的标准言语任务。使用构音障碍分析仪给出的算法自动提取声学言语特征。结果表明,急性摄入左旋多巴可改善发声-呼吸言语功能和言语规划能力,而发音系统不受影响。此外,该研究提供了初步证据,表明言语功能能够预测PD患者的用药状态,因为构建的基于言语的生物标志物评分不仅与既定的(言语)运动障碍测量指标相关,还能区分停药和服药状态。事后机器学习模型也得出了类似的结果。